Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In these randomized, placebo-controlled trials, patients with alopecia areata who received baricitinib showed significantly higher eyebrow and eyelash hair regrowth rates compared to placebo, with greater responses observed at the 4 mg dose and in those achieving overall scalp hair improvement by Week 52.

This study evaluated eyebrow mesotherapy with a growth factor-based cocktail in 32 women with thin eyebrows, finding high satisfaction rates (90.6%) with significant improvements in density and appearance, low pain levels, and unanimous willingness to recommend the treatment.

This study found that trichoscopy is a valid and sensitive tool for diagnosing and evaluating eyebrow involvement in lichen planopilaris and frontal fibrosing alopecia.

In this study, patients with severe alopecia areata treated with baricitinib over 152 weeks experienced sustained patient-reported improvements in scalp, eyebrow, and eyelash hair regrowth, with higher responders observed in the 4mg dose group compared to the 2mg group.

In this study, patients with severe alopecia areata treated with baricitinib showed continued improvement in scalp hair regrowth from weeks 52 to 152, particularly among those initially responding with eyelash or eyebrow regrowth but not scalp hair, with 39% achieving substantial regrowth by week 104.

Eyebrow and eyelash regrowth usually matches scalp hair response in alopecia areata patients treated with baricitinib.

This study found that bimatoprost was significantly more effective than sweet almond oil in increasing eyebrow hair density and length in young women over a 5-week period.

This study found that among placebo-treated patients in the BRAVE-AA trials, the likelihood of spontaneous hair regrowth in untreated severe alopecia areata was low, with only a small percentage achieving significant scalp, eyebrow, or eyelash hair improvement over 36 weeks.

In this study, Saudi Arabian women showed moderate awareness of eyebrow microblading, yet many lacked knowledge of hygiene practices, indicating a need for more public education on the procedure's risks and standards.

In this study, a strong positive correlation was found between clinician-reported and patient-reported measures for assessing eyebrow and eyelash hair loss in patients with severe alopecia areata, indicating high agreement during treatment with baricitinib over 52 weeks.

This study observed that blepharoptosis surgery resulted in brow lowering at various points on the eyebrow, with the most significant change at the medial canthus. The researchers reported that preoperative brow position was the main predictor of brow height descent after surgery.

This study aimed to describe the distribution of eyebrow and eyelash hair loss in patients with varying severities of scalp hair loss from alopecia areata but does not report results.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

This study found that some patients with alopecia areata who did not respond to ritlecitinib treatment by Week 24 achieved a positive response with continued therapy by Week 48, with tolerable side effects.

This study explored a new treatment approach using 20% TCA application with topical bimatoprost solution for managing alopecia areata of the eyebrows in cases where traditional treatments failed, offering a potential additional option for difficult cases.

This study aims to provide a practical guide for managing common causes of madarosis, highlighting the need to identify underlying causes to ensure effective treatment for eyelash and eyebrow loss.

This article discusses the complexities of brow hair restoration and reports no new clinical results, emphasizing the meticulous and technically demanding nature of this procedure.

This study found that baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata, with similar improvements observed in both clinician-reported and patient-reported measures.

This protocol outlines a study aiming to develop a universal patient-reported outcome measure for various hair disorders through qualitative interviews, with no new clinical results reported yet.

This study found that eyebrow involvement in frontal fibrosing alopecia was more common among postmenopausal females with comorbidities, without a significant link to age or disease duration.

This abstract reviews eyebrow transplantation techniques, highlighting that follicular unit extraction prevents scarring at the donor site, unlike strip harvesting, and reports no new clinical results.

This study discusses eyebrow reconstruction techniques, highlighting the correction of unsatisfactory transplants using donor hair without laser or tattoos, focusing on factors like hair follicle density and eyebrow shape.

This chapter reviews techniques and considerations for facial hair transplantation, including the restoration of beards and eyebrows, and provides guidance on candidate selection and managing complications, reporting no new clinical results.

This study reported that while eyebrow hair transplantation in patients with frontal fibrosing alopecia achieves satisfactory short-term results, most patients experience significant hair graft loss within 3-4 years.

This chapter outlines eyebrow aging and aesthetics and describes a five-step approach using neurotoxin and filler synergy to enhance eyebrow appearance, but reports no new clinical results.

This article presents eyebrow transplantation techniques developed from over 1,000 procedures at the authors' clinic, with no new clinical outcomes reported.

In this pilot study, eyebrow mesotherapy was reported to achieve clinically apparent thickening and darkening of eyebrows, with 8 out of 12 patients satisfied with the results after 15 days.

This study observed that certain changes in facial "heart representation areas," like eyebrow hair whitening and loss, are associated with cardiovascular issues and may correspond with increased Cardiac Troponin I levels.

This study found that a simple surgical technique for eyebrow restoration using hair follicle transplantation yielded satisfactory results in all 18 cases.

This study found that SULT1A1 enzyme activity, crucial for activating minoxidil, is significantly lower in eyebrow and eyelash follicles compared to scalp follicles, suggesting that additional sulfotransferase supplementation might enhance minoxidil-based hair growth treatments for these areas.